Which of the following drugs for moderate-to-severe psoriasis inhibits both IL-12 and IL23?
Correct Answer: Ustekinumab
Description: Alefacept is anti CD-2 for psoriasis
Efalizumab is anti CD-11a for psoriasis
Ustekinumab targets the p40 subunit of both IL-12 and IL-23 in psoriasis
Abatacept is anti CD-80 and CD-86 for severe RA
Category:
Unknown
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now